| Patent application number | Description | Published |
|---|
| 20080207654 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF - A compound represented by the formula (I): | 08-28-2008 |
| 20090176812 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF - A compound represented by the formula (I): | 07-09-2009 |
| 20100056526 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF - A compound represented by the formula (I): wherein R1 is an oxo group, ═N—R or the like; a group represented by the formula: is a group represented by the formula: R2 is a group represented by the formula: or a salt thereof. The compound of the present invention is useful as a drug for the prophylaxis or treatment of circulatory diseases, metabolic diseases and/or central nervous system diseases. | 03-04-2010 |
| 20100105709 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF - A compound represented by the formula (I): | 04-29-2010 |
| 20100113780 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF - A compound represented by the formula (I): | 05-06-2010 |
| 20100137281 | HETEROCYCLIC COMPOUND AND USE THEREOF - The present invention aims to provide a compound having superior pharmacological action, physicochemical properties and the like, which is useful for the prophylaxis or treatment s of circulatory diseases such as hypertension, cardiac diseases, arteriosclerosis, renal diseases, cerebral apoplexy and the like and/or metabolic diseases such as hyperlipidemia, obesity, diabetes and the like, central nervous disorders such as cerebral infarction and the like, mental diseases such as dementia, depression and the like, and the like. | 06-03-2010 |
| 20100197683 | FUSED RING COMPOUND AND USE THEREOF - Provided is a novel compound represented by the following formula | 08-05-2010 |
| 20110112120 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF - A compound represented by the formula (I): | 05-12-2011 |
